Ellipsis Health

Ellipsis Health

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.ellipsishealth.com

Last Round

Series A

Extension

Jun 12, 2025

Total Funding Raised

$120.02M

Momentum Score

25 /100

Company Overview

Ellipsis Health is a healthcare technology company that offers a behavioral biomarker platform to assess and predict patients' mental health, focusing on anxiety, depression, and stress levels for improved clinical screening.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical AI, Patient Engagement, NLP & Conversational AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Usage-Based SaaS

AI Layer

Application

Keywords

vocal biomarkersAI care manageremotionally intelligent AIdepression and anxiety screeningvoice AImental health screeningbehavioral health AIpatient engagement platformcare management automationspeech analysisremote patient monitoringhealthcare AI agenthealthcare APIpayer solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ellipsis Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ellipsis Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 12, 2025
Series AJun 12, 2025
Series AAug 31, 2021
VC RoundFeb 4, 2021
SeedDec 12, 2017

Key People

Founding team and executive leadership

Mainul Mondal

Founder CEO

Founding Team

Ajit Verma

Chief Technology Officer, Advisor

Executive Team

Melissa McCool

Chief Product Officer, Chief Operating Officer

Executive Team

Angela Suthrave

Chief Product Officer

Executive Team

Ellipsis Health Investors

Notable investors and investment history

InvestorRounds
Collier VenturesSeries A
Aetna VenturesSeries A Extension, Series A
Able PartnersSeries A, VC Round
Mitsui Global InvestmentSeries A Extension, Series A
10X CapitalVC Round
Khosla VenturesSeed, Series A, Series A Extension
Generator VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    Partnered with HealthEdge Software to integrate AI care management voice agent.

  • Mar 24, 2026

    Collaboration aims to increase enrollment in patient care programs.

Ellipsis Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ellipsis Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ellipsis Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range66
Year Founded2017
Last FundingJun 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.